Evidence map›Paper›PMID 33782875›Full record

ArticleAdvances in experimental medicine and biology2021

Bioapplications of Nanomaterials.

Kim-Hung Huynh, Kwee-Yum Lee, Hyejin Chang, Sang Hun Lee, Jaehi Kim, Xuan-Hung Pham, Yoon-Sik Lee, Won-Yeop Rho, Bong-Hyun Jun

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kim-Hung HuynhDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, South Korea.
Kwee-Yum LeeRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Hyejin ChangDivision of Science Education, Kangwon National University, Chuncheon, Republic of Korea.
Sang Hun LeeDepartment of Chemical and Biological Engineering, Hanbat National University, Daejeon, Republic of Korea.
Jaehi KimDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, South Korea.
Xuan-Hung PhamDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, South Korea.
Yoon-Sik LeeSchool of Chemical and Biological Engineering, Seoul National University, Seoul, Republic of Korea.
Won-Yeop RhoSchool of International Engineering and Science, Jeonbuk National University, Jeonju, Republic of Korea. rho7272@jbnu.ac.kr.
Bong-Hyun JunDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, South Korea. bjun@konkuk.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanobiotechnology is known as the application of nanoscaled techniques in biology which bridges natural science to living organism for improving the quality of life of humans. Nanotechnology was first issued in 1959 and has been rapidly developed, supplying numerous benefits to basic scientific academy and to clinical application including human healthcare, specifically in cancer therapy. This chapter discusses recent advances and potentials of nanotechnology in pharmaceutics, therapeutics, biosensing, bioimaging, and gene delivery that demonstrate the multifunctionality of nanotechnology.

Indexed as

Biosensing TechniquesNanostructuresDrug Delivery SystemsGene Transfer TechniquesHumansNanomedicineNanotechnologyQuality of LifeBioapplicationBioimagingBiosensingCancer therapeuticsDrug deliveryNanomaterialNanomedicine

Identifiers

PMID33782875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.